How Predictive Modelling Can Change Personalised Medicine
Personalised medicine - treatments which focus on the individual patient or sub-population, not simply prescribing a generic treatment to a large swathe of patients - has been a key target in healthcare for a long time now. New technologies, including...
3 years agoHow Predictive Modelling Can Change Personalised Medicine
Personalised medicine - treatments which focus on the individual patient or sub-population, not simply prescribing a generic treatment to a large swathe of patients - has been a key target in healthcare for a long time now. New technologies, including...
3 years ago
The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu
Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...
3 years agoThe Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu
Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...
3 years ago
Protein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
3 years agoProtein-Based Diagnostic Biomarkers for Cancer: Where Are We Now?
While significant progression has been made in cancer therapeutics, the disease remains a serious health risk. The lack of commercially available diagnostic biomarkers hinders accurate early cancer diagnosis which could otherwise save many lives. Protein-based biomarkers have demonstrated the potential...
3 years ago
Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
3 years agoSupporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
3 years ago
The Opportunities and Challenges of Remote Patient Monitoring
The success of decentralised clinical trials during the pandemic was dependent on telemedicine to monitor patient health and collect data. Actigraphy bracelets and video consultations are a few examples of how patients can be monitored remotely for healthcare and data...
3 years agoThe Opportunities and Challenges of Remote Patient Monitoring
The success of decentralised clinical trials during the pandemic was dependent on telemedicine to monitor patient health and collect data. Actigraphy bracelets and video consultations are a few examples of how patients can be monitored remotely for healthcare and data...
3 years ago
The Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years agoThe Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years ago
Future Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
3 years agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
3 years ago
Strategies to Optimise Companion Diagnostics in Cancer
Companion diagnostic tests are an important part of precision medicine in oncology. In addition to matching optimal treatment options for patients, these tests enable clinicians to monitor the efficacy of therapeutic intervention in disease management. Innovations in cancer biopsies and...
3 years agoStrategies to Optimise Companion Diagnostics in Cancer
Companion diagnostic tests are an important part of precision medicine in oncology. In addition to matching optimal treatment options for patients, these tests enable clinicians to monitor the efficacy of therapeutic intervention in disease management. Innovations in cancer biopsies and...
3 years ago
Phenotypic Screening in Early Drug Discovery: Opportunities and Challenges
Despite the prevalence of target-based discovery, phenotypic screening is emerging as a popular technique in early drug discovery. Challenges with target-based delivery have shown obvious flaws with predictive validity. The latest application of AI in phenotypic drug discovery has shown...
3 years agoPhenotypic Screening in Early Drug Discovery: Opportunities and Challenges
Despite the prevalence of target-based discovery, phenotypic screening is emerging as a popular technique in early drug discovery. Challenges with target-based delivery have shown obvious flaws with predictive validity. The latest application of AI in phenotypic drug discovery has shown...
3 years ago
The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
3 years agoThe Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
3 years ago